CNBC June 13, 2019
Tyler Clifford

  • Dexcom CEO Kevin Sayer says its G6 upgrade for the Apple Watch will be a “great for people with diabetes.”
  • A separate collaboration with Alphabet-subsidiary Verily will also be a device “for the ages,” he says.
  • The medical device company wants to expand its relationships with Walgreens and CVS to “get the product to the patient where they can use it,′ he says.

Dexcom will launch a number of upgrades for its G6 diabetes system over the next year, including its direct-to-Apple Watch version, CEO Kevin Sayer said Thursday.

Apple CEO Tim Cook earlier this year said he wanted to leave a mark on the health care industry under his tenure at the iconic technology giant. The collaboration...